• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测上尿路尿路上皮癌的侵袭性和疾病特异性生存:确定相关的临床肿瘤特征。

Predicting invasiveness and disease-specific survival in upper tract urothelial carcinoma: identifying relevant clinical tumour characteristics.

机构信息

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

Department of Urology, Stockholm South General Hospital, Stockholm, Sweden.

出版信息

World J Urol. 2019 Nov;37(11):2335-2342. doi: 10.1007/s00345-019-02760-4. Epub 2019 Apr 23.

DOI:10.1007/s00345-019-02760-4
PMID:31016451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6825649/
Abstract

PURPOSE

The aim of this prospective study was to identify the tumour characteristics that are associated with invasiveness and those that are relevant for disease-specific survival (DSS) in upper tract urothelial carcinoma, UTUC.

METHODS

From a prospective consecutive cohort of patients with suspicion of UTUC, those who were diagnosed with UTUC using URS prior to rNU between 2005 and 2012 were included. Tumour characteristics were analysed for prediction of invasiveness and association with DSS. Stages were categorised as superficial (pTa-1 and CIS only) or invasive (≥  pT2). Tumours were graded according to WHO 1999 classification. DSS was analysed regarding possible association with stage, grade, size, multifocality, location, ploidy and rate of proliferation. Associations were tested using Fisher's exact test, Pearson Chi-square or Cox's regression. Kaplan-Meier survival curves were constructed.

RESULTS

Forty-five consecutive patients were included, and 43 of them were included in the final analyses because their rNU specimens were available for reassessment. The only tumour characteristics that were significantly associated with stage were tumour grade (P < 0.001), DNA ploidy (P = 0.045) and rate of proliferation (P = 0.004). No association with stage was noted for size, multifocality or location. Grade, stage and rate of proliferation were associated with DSS.

CONCLUSIONS

Grade, DNA ploidy and S-phase fraction were the only tumour characteristics associated with stage in our study. However, DNA ploidy was not associated with DSS. The prognostic factors that we identified were tumour grade, stage, and S-phase fraction.

摘要

目的

本前瞻性研究旨在确定与上尿路上皮癌(UTUC)侵袭性相关的肿瘤特征和与疾病特异性生存(DSS)相关的肿瘤特征。

方法

从 2005 年至 2012 年间,通过输尿管镜检查怀疑患有 UTUC 的连续前瞻性队列中,纳入了接受经尿道输尿管镜肾实质切开术(rNU)前诊断为 UTUC 的患者。分析肿瘤特征以预测侵袭性和与 DSS 的关联。分期分为表浅(仅 pTa-1 和 CIS)或浸润性(≥pT2)。肿瘤分级根据世界卫生组织 1999 年分类进行。分析 DSS 与分期、分级、大小、多灶性、位置、倍性和增殖率的可能相关性。使用 Fisher 确切检验、Pearson 卡方检验或 Cox 回归检验进行关联测试。构建 Kaplan-Meier 生存曲线。

结果

纳入了 45 例连续患者,其中 43 例最终纳入分析,因为他们的 rNU 标本可用于重新评估。与分期显著相关的唯一肿瘤特征是肿瘤分级(P<0.001)、DNA 倍性(P=0.045)和增殖率(P=0.004)。肿瘤大小、多灶性或位置与分期无关联。分级、分期和增殖率与 DSS 相关。

结论

在我们的研究中,只有分级、DNA 倍性和 S 期分数与分期相关。然而,DNA 倍性与 DSS 无关。我们确定的预后因素是肿瘤分级、分期和 S 期分数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db31/6825649/758c9cf9ee4f/345_2019_2760_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db31/6825649/758c9cf9ee4f/345_2019_2760_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db31/6825649/758c9cf9ee4f/345_2019_2760_Fig1_HTML.jpg

相似文献

1
Predicting invasiveness and disease-specific survival in upper tract urothelial carcinoma: identifying relevant clinical tumour characteristics.预测上尿路尿路上皮癌的侵袭性和疾病特异性生存:确定相关的临床肿瘤特征。
World J Urol. 2019 Nov;37(11):2335-2342. doi: 10.1007/s00345-019-02760-4. Epub 2019 Apr 23.
2
Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.诊断性输尿管镜活检对预测上尿路尿路上皮癌膀胱内复发的价值分析。
Urol Int. 2022;106(2):186-194. doi: 10.1159/000517789. Epub 2021 Sep 7.
3
Grading of urothelial carcinoma of the upper urinary tract according to the World Health Organization/International Society of Urological Pathology classification from 2004 is a valuable tool when considering whether a patient is suitable for endoscopic treatment.根据2004年世界卫生组织/国际泌尿病理学会分类对上尿路尿路上皮癌进行分级,在考虑患者是否适合内镜治疗时是一种有价值的工具。
Scand J Urol. 2016 Aug;50(4):298-304. doi: 10.3109/21681805.2016.1144220. Epub 2016 Feb 29.
4
Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.肿瘤大小对根治性肾输尿管切除术后上尿路尿路上皮癌预后的影响:795例多机构分析
BJU Int. 2016 Dec;118(6):902-910. doi: 10.1111/bju.13463. Epub 2016 Mar 27.
5
Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.根治性肾输尿管切除术治疗上尿路上皮癌的预后指标:淋巴血管侵犯的影响。
BJU Int. 2012 Sep;110(6):798-803. doi: 10.1111/j.1464-410X.2011.10893.x. Epub 2012 Feb 7.
6
[Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma: an analysis of 368 radical nephroureterectomy specimens].上尿路尿路上皮癌的临床病理特征及预后:368例根治性肾输尿管切除术标本分析
Zhonghua Bing Li Xue Za Zhi. 2016 Oct 8;45(10):681-686. doi: 10.3760/cma.j.issn.0529-5807.2016.10.003.
7
Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.血浆纤维蛋白原水平对局限性上尿路尿路上皮癌患者的预后价值。
BJU Int. 2013 May;111(6):857-64. doi: 10.1111/j.1464-410X.2012.11353.x. Epub 2012 Jul 3.
8
Longer is Better for Endoscopic Follow-up of Upper Tract Urothelial Carcinoma After Ureteroscopic Treatment: An Evaluation Spanning 10 Years of Data.输尿管镜治疗后上尿路尿路上皮癌内镜随访时间延长更好:跨越 10 年数据的评估。
Eur Urol Oncol. 2024 Aug;7(4):853-859. doi: 10.1016/j.euo.2023.11.017. Epub 2023 Dec 5.
9
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.肾输尿管切除术和节段性输尿管切除术治疗浸润性上尿路尿路上皮癌:2299 例患者的基于人群研究。
Eur J Cancer. 2009 Dec;45(18):3291-7. doi: 10.1016/j.ejca.2009.06.016. Epub 2009 Jul 15.
10
Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.内镜与腹腔镜治疗非浸润性上尿路尿路上皮癌:20 年单中心经验。
J Urol. 2013 Jun;189(6):2054-60. doi: 10.1016/j.juro.2012.12.006. Epub 2012 Dec 7.

引用本文的文献

1
Diagnosing upper tract urothelial carcinoma: A review of the role of diagnostic ureteroscopy and novel developments over last two decades.诊断上尿路尿路上皮癌:过去二十年诊断性输尿管镜检查作用及新进展综述
Asian J Urol. 2024 Apr;11(2):242-252. doi: 10.1016/j.ajur.2022.08.003. Epub 2022 Sep 23.
2
Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods-what's around the corner?2022 年斯德哥尔摩 UTUC II 咨询会:诊断和预后方法——未来的发展方向是什么?
World J Urol. 2023 Dec;41(12):3405-3411. doi: 10.1007/s00345-023-04597-4. Epub 2023 Sep 19.
3
Consultation on UTUC II Stockholm 2022: diagnostics, prognostication, and follow-up-where are we today?

本文引用的文献

1
Discordance between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial Carcinoma.输尿管镜活检与上尿路尿路上皮癌最终病理的不相符。
J Urol. 2018 Jun;199(6):1440-1445. doi: 10.1016/j.juro.2018.02.002. Epub 2018 Feb 7.
2
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2017 年更新版。
Eur Urol. 2018 Jan;73(1):111-122. doi: 10.1016/j.eururo.2017.07.036. Epub 2017 Sep 1.
3
Which Patients with Upper Tract Urothelial Carcinoma Can be Safely Treated with Flexible Ureteroscopy with Holmium:YAG Laser Photoablation? Long-Term Results from a High Volume Institution.
2022 年斯德哥尔摩 UTUC II 咨询会议:诊断、预后和随访——我们今天在哪里?
World J Urol. 2023 Dec;41(12):3395-3403. doi: 10.1007/s00345-023-04530-9. Epub 2023 Aug 4.
4
Prognostic impact of perirenal fat stranding on oncologic outcomes in ureteral urothelial carcinoma.肾周脂肪条索征对尿路上皮癌肿瘤学结局的预后影响。
Investig Clin Urol. 2021 Jan;62(1):23-31. doi: 10.4111/icu.20200125. Epub 2020 Dec 9.
5
Consultation on UTUC Stockholm 2018.2018年斯德哥尔摩上尿路上皮癌咨询会
World J Urol. 2019 Nov;37(11):2269-2270. doi: 10.1007/s00345-019-02932-2.
6
Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma.容积成像:一种潜在的上尿路尿路上皮癌分期工具。
World J Urol. 2019 Nov;37(11):2297-2302. doi: 10.1007/s00345-019-02682-1. Epub 2019 Feb 28.
哪些上尿路尿路上皮癌患者可以安全地接受钬激光:钇铝石榴石激光光凝的软性输尿管镜治疗?来自一家大型机构的长期结果。
J Urol. 2018 Jan;199(1):66-73. doi: 10.1016/j.juro.2017.07.088. Epub 2017 Aug 15.
4
Diagnostic accuracy of upper tract urothelial carcinoma: how samples are collected matters.上尿路尿路上皮癌的诊断准确性:样本采集方式至关重要。
Scand J Urol. 2017 Apr;51(2):137-145. doi: 10.1080/21681805.2017.1295102. Epub 2017 Apr 7.
5
Diagnostic accuracy of computed tomography urography and visual assessment during ureterorenoscopy in upper tract urothelial carcinoma.输尿管肾盂镜检查时计算机断层扫描尿路造影及视觉评估在上尿路尿路上皮癌中的诊断准确性
BJU Int. 2017 Feb;119(2):289-297. doi: 10.1111/bju.13652. Epub 2016 Oct 3.
6
Optical Coherence Tomography as a Tool for In Vivo Staging and Grading of Upper Urinary Tract Urothelial Carcinoma: A Study of Diagnostic Accuracy.光学相干断层扫描作为一种用于上尿路尿路上皮癌的体内分期和分级的工具:诊断准确性研究。
J Urol. 2016 Dec;196(6):1749-1755. doi: 10.1016/j.juro.2016.04.117. Epub 2016 Jul 27.
7
Histopathologic Characteristics of Upper Tract Urothelial Carcinoma With an Emphasis on Their Effect on Cancer Survival: A Single-Institute Experience With 305 Patients With Long-Term Follow-Up.上尿路尿路上皮癌的组织病理学特征及其对癌症生存的影响:一家机构对305例患者的长期随访经验
Clin Genitourin Cancer. 2016 Dec;14(6):e609-e615. doi: 10.1016/j.clgc.2016.04.017. Epub 2016 May 5.
8
The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma.肿瘤大小对上尿路尿路上皮癌患者预后的影响。
Int Urol Nephrol. 2014 Mar;46(3):563-9. doi: 10.1007/s11255-013-0533-9. Epub 2013 Sep 21.
9
Utility and diagnostic accuracy of ureteroscopic biopsy in upper tract urothelial carcinoma.输尿管镜活检在上尿路尿路上皮癌中的应用及诊断准确性。
Arch Pathol Lab Med. 2013 Mar;137(3):400-7. doi: 10.5858/arpa.2012-0136-OA.
10
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.经输尿管镜和经皮处理上尿路尿路上皮癌(UTUC):系统综述。
BJU Int. 2012 Sep;110(5):614-28. doi: 10.1111/j.1464-410X.2012.11068.x. Epub 2012 Apr 3.